LiveWire Group, Inc.
LVWRInvestment snapshot
Positive
2
BUY / PASS
Neutral / negative
2 / 12
NEUTRAL / FAIL
Median fair value
—
No comparable estimates
Models with upside
0 / 17
Positive margin of safety
Key risk
No clean pass — all 12 investors flag at least one debt & leverage criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #2929 (Top 94.6%) | PASS | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | PASS | FAIL | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Margin of Safety | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | TTM ended 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-20 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-20 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-20 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-20 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-04 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-11-04 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Debt & Leverage0% pass✓ 2✗ 13▾
No clean pass — all 12 investors flag at least one debt & leverage criterion
LT Debt vs Net Current AssetsLT Debt $76.8M vs NCA $42.4M✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 1.63, IC: -296.0x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / EquityN/A (negative equity)✗Lynch< 0.33Cash - Long-term Debt$-36.9M✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 50.67%✗PiotroskiDecreased YoYCurrent Assets / Current Liabilities3.09✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00xDebt LevelsN/A (non-positive equity)✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=-296.0x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity✗Ackman<= 1.0Negative debt-to-equity (higher means less debt)✗AsnessTop 30% of eligible cross-section - Valuation0% pass✓ 5✗ 23▾
No clean pass — all 13 investors flag at least one valuation criterion
Price / Book Value per Share1.3x✗Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio1.3x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value-72.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-72.0%, ROC=-269.3%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xValuation ReasonablenessOE Yield=-112.4%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldFCF Yield=-93.1%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=1.3x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per ShareN/A (negative FCF)✗Ackman<= 25Price vs. Trailing Low100% of trailing low ($0.30)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-117.79%; #5472/6340 (top 86.3%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization-0.0896; #5694/6449 (top 88.3%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1.66x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+1695.5%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.5428; #2524/5247 (top 48.1%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization-80.82%; #4009/4519 (top 88.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-78.72%; #5814/6202 (top 93.7%)✗OshaughnessyTop 10% of eligible cross-section - Cash Flow0% pass✓ 1✗ 11▾
No clean pass — all 10 investors flag at least one cash flow criterion
Free Cash Flow Proxy$-68.8M✗BuffettPositive and growingFCF Positive and Growing$-49.8M✗LynchPositive and growingOperating Cash Flow$-53.5M✗PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=-36.57%, ROA=-51.30%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xP/E or FCF YieldFCF Yield=-93.1%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive0/6 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap-81.4%✗Ackman>= 4%Price / FCF per ShareN/A (negative FCF)✗Ackman<= 25Positive Operating Cash Flow frequency0/6 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$-49.8M✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization-80.82%; #4009/4519 (top 88.7%)✗OshaughnessyTop 10% of eligible cross-section - Growth0% pass✓ 2✗ 11▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -31.4% vs Rev: 33.4%✓LynchInventory growth < Revenue growthEPS Growth Direction$-0.48 (2020) -> $-0.37 (2025)✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency0/6 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-18.8%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin -15.2% -> -17.3%, operating margin -305.0% -> -294.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR-3.6%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Profitability6% pass✓ 5✗ 30▾
15 of 16 flag LVWR's profitability — Graham, Buffett, Lynch +12 more
Positive EPS (10 years)0/7 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)0/7 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-133.3%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-294.0% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$-68.8M✗BuffettPositive and growingEarnings Variance (10-yr CoV)N/A (negative mean EPS)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROEN/A (negative equity)✗Lynch> 15%EBIT / Enterprise Value-72.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-72.0%, ROC=-269.3%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets-51.30%✗PiotroskiROA > 0ROA Change YoY-63.48% -> -51.30% (delta: +12.18%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=-36.57%, ROA=-51.30%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY-48.0% -> -17.3%✓PiotroskiImproved YoYPre-Tax Income / Revenue-218.7%✗Dreman>= 8%Net Income / Shareholders' Equity✗Dreman> 12%Margin of SafetyP/B=1.3x✓PabraiP/B < 1.5 or P/E < 15Return on Equity-99.3% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency0/6 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue-212.1%✗Ackman>= 15%Net Income / Shareholders Equity✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-305.0% (2023) -> -294.0% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin -15.2% -> -17.3%, operating margin -305.0% -> -294.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-117.79%; #5472/6340 (top 86.3%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets-3.03%; #3597/3702 (top 97.2%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.2950; #4591/5884 (top 78.0%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years0/6 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts13% pass✓ 2✗ 13▾
Split decision: 12 FAIL · 2 PASS · 2 NEUTRAL
Overall verdict✗GrahamFAIL (2/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)✗GreenblattRank #2929✓PiotroskiPASS (F-Score 4)✗DremanFAIL (1/11)✗MungerFAIL (0/4)✗PabraiFAIL (1/3)✗AkreFAIL (0/6)✗MarksFAIL (1/5)✗AckmanFAIL (2/9)✓TempletonPASS (4/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (0/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Efficiency25% pass✓ 3✗ 8▾
6 of 8 flag LVWR's efficiency — Buffett, Greenblatt, Piotroski +3 more
Current Ratio3.09✓Graham>= 2.0ROIC (3-5 yr avg)-199.9%✗Buffett> 10%ROIC - WACC-209.9%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)-269.3%✗Greenblatt> 25%Current Ratio Change YoY3.29 -> 4.63✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.18x -> 0.18x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities3.09✓Dreman> 1.5Return on Invested Capital-78.6%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=-75.7%; FY2025: ROIC=-49.3%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROICN/A (non-positive net income)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/4 years above 12% (latest -49.3%)✗SleepROIC > 12% in a majority of years
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 0.4% of shares last year, 0.5% issued over two.
- Buybacks
- $1.0M
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, operating cash flow, depreciation amortization, capex, buybacks. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, buybacks. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, buybacks. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $61.6Mcurrent | -- | -- | -- | $477.4Mest. | $640.3Mest. | $2.0Best. | $1.3Best. | $1.6Best. |
| Revenue | $33.4M↑33% | $7.9M↑38% | $9.1M↑55% | $5.1M↑86% | $25.7M↓4% | $26.6M↓30% | $38.0M↓19% | $46.8M↑31% | $35.8M |
| Operating Income | -$70.9M↑15% | -$17.5M↑7% | -$18.0M↑1% | -$17.7M↑14% | -$75.5M↑32% | -$110.4M↑5% | -$116.0M↓37% | -$85.0M↓25% | -$68.2M |
| Net Income | -$72.6M↑10% | -$18.6M↑4% | -$18.2M↑3% | -$18.1M↑6% | -$75.1M↑20% | -$93.9M↑14% | -$109.5M↓39% | -$78.9M↓16% | -$68.3M |
| EPS (Diluted) | -- | $-0.09↑10% | $-0.09 | $-0.09 | $-0.37↑20% | $-0.46↑15% | $-0.54↓17% | $-0.46↓10% | $-0.42 |
| Gross Margin | — | — | — | — | -17.3%↑64% | -48.0%↓216% | -15.2%↓345% | 6.2%↑186% | -7.2% |
| Operating Margin | -212.1%↑36% | -222.7%↑33% | -197.6%↑36% | -345.5%↑54% | -294.0%↑29% | -414.4%↓36% | -305.0%↓68% | -181.4%↑5% | -190.4% |
| ROE | 1314.2%↑1112% | — | — | — | -163.2%↓100% | -81.6%↓53% | -53.2%↓107% | -25.7%↑92% | -342.7% |
| Total Debt | $76.8M | $76.8M | $76.8M | $74.2M | $75.0M | $0 | -- | $0↓100% | $103.0K |
| Shareholders' Equity | -$5.5M↓109% | -$5.5M↓109% | $11.9M↓85% | $28.3M↓71% | $46.0M↓60% | $115.1M↓44% | $205.9M↓33% | $306.8M↑1440% | $19.9M |
| Current Ratio | 3.09↑61% | 3.09↑61% | 4.16↑74% | 4.29↑50% | 4.63↑40% | 3.29↓28% | 4.55↓48% | 8.77↑653% | 1.16 |
| Debt / Equity | -13.91 | -13.91 | 6.44 | 2.62 | 1.63 | 0.00 | — | 0.00↓100% | 0.01 |
| Operating Cash Flow | -$46.2M↑32% | -$11.9M↑10% | -$13.4M↑10% | -$13.0M↑26% | -$53.5M↑43% | -$93.9M↓12% | -$83.5M↑7% | -$89.7M↓20% | -$74.5M |
| Free Cash Flow | -$49.8M↑31% | -$12.9M↑8% | -$14.3M↑13% | -$13.7M↑24% | -$57.4M↑44% | -$101.9M↓5% | -$96.9M↑7% | -$103.8M↓23% | -$84.5M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Consumer Goods
LVWR vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNILEVER PLCUL | $142.6B | $66.21 | $59.3B | $11.1B | 61.0% | 1.68 | 17.9% | 0.79 | 2/9 | 4/9 | 4/7 | 1/3 | F-Score 8 | 6/11 |
| ECOLAB INC.ECL | $86.7B | $309.27 | $16.1B | $2.1B | 21.2% | 0.84 | 17.0% | 1.08 | 3/9 | 5/9 | 3/7 | 1/3 | F-Score 6 | 5/11 |
| COLGATE PALMOLIVE COCL | $79.2B | $99.67 | $20.4B | $2.1B | 3948.1% | 147.89 | 16.2% | 0.83 | 2/9 | 5/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| ESTEE LAUDER COMPANIES INCEL | $40.5B | $111.75 | $14.3B | $1.1B | -29.3% | 1.89 | -5.5% | 1.30 | 2/9 | 4/9 | 2/7 | 0/3 | F-Score 6 | 1/11 |
| CHURCH & DWIGHT CO INC /DE/CHD | $26.7B | $113.00 | $6.2B | $736.8M | 18.4% | 0.55 | 17.4% | 1.07 | 3/9 | 7/9 | 3/7 | 1/3 | F-Score 7 | 4/11 |
| CANON INCCAJPY | $25.2B | $30.28 | — | — | — | — | — | — | 3/9 | 1/9 | 1/7 | 1/3 | F-Score 7 | 5/11 |
| SOMNIGROUP INTERNATIONAL INC.SGI | $14.0B | $60.76 | $7.5B | $384.1M | 12.4% | 1.51 | 10.1% | 0.83 | 1/9 | 5/9 | 2/7 | 1/3 | F-Score 5 | 2/11 |
| INTERPARFUMS INCIPAR | $4.3B | $133.37 | $1.5B | $168.4M | 19.1% | 0.20 | 18.2% | 2.99 | 4/9 | 5/9 | 6/7 | 1/3 | F-Score 5 | 7/11 |